article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

The company, a spin-out from the UW’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. Icosavax is also developing shots, geared for older adults, against two viruses that cause pneumonia, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Net losses were $5.3

article thumbnail

This startup is developing an animal collar that automatically administers topical medicine

GeekWire

Recent advances in ink jet printing and microfluidics tech have made developing a smart collar device possible, he added. ” The 7-person startup was founded by Michael Manion , who also runs a research and development company called Keon Research. A prototype of the JetMeds collar. JetMeds Photo).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nvidia and Siemens to accelerate digital twins’ development

CIO Business Intelligence

Nvidia made its name designing chips that can dramatically accelerate certain kinds of calculations — those involved in rendering 3D models, for instance — but has recently moved into software development. This will begin with 400 offerings in four domains: real estate, utilities, healthcare, and pharmaceuticals, Koerte said.

article thumbnail

How Nvidia became a trillion-dollar company

CIO Business Intelligence

Still, software developers seeking to leverage graphics chips for non-graphical applications had to wrangle their calculations into a form that could be sent to the GPU as a series of instructions for either Microsoft’s DirectX graphics API or the open-source OpenGL (Open Graphics Library).

Company 98
article thumbnail

Gen AI: Should you build or buy?

CIO Business Intelligence

With organizations racing to put more generative AI tools in users’ hands—and software vendors rapidly integrating those tools into their products—CIOs face a familiar choice: develop their own solutions in house, or invest and adapt tools already available in a fast-growing AI marketplace. Yet it’s not a simple build-vs.-buy

article thumbnail

Generative AI usage gains traction among enterprises: McKinsey

CIO Business Intelligence

The findings also showed that the most commonly reported uses of generative AI are in marketing, sales, product development, and service operations. Artificial Intelligence, Enterprise Applications, Generative AI

article thumbnail

Merck Life Sciences banks on RPA to streamline regulatory compliance

CIO Business Intelligence

The pharmaceutical industry is a highly regulated one, especially for multinationals doing business across the globe. Merck Life Sciences, a leading chemical and pharmaceutical company, with 60,000 employees working across 66 countries, was one of them. In the development control room, there are 25 users with different roles.

Banking 98